Citation

Timothy J. Wilkin, Roy (Trip) Gulick, Athe Tsibris, Daniel R. Kuritzkes, Roger Paredes, Amy Chadburn, Zhaohui Su, Timothy Henrich, Amy Krambrink, Michael Hughes, Judith A. Aberg, Judith Silverstein Currier, Karen T. Tashima, Catherine Godfrey, Wayne Greaves, Charles Flexner, Paul Skolnik. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS clinical trials group A5211. Clinical Infectious Diseases. 2009. 48: 642-9.

Citation

Charles Flexner, Chad Nusbaum, Athe Tsibris, Daniel R. Kuritzkes, Bette T. Korber, Ramy Arnaout, Carsten Russ, Chien-Chi Lo, Thomas Leitner, Brian Gaschen, James Theiler, Roger Paredes, Zhaohui Su, Michael Hughes, Roy (Trip) Gulick, Wayne Greaves, Eoin Coakley. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. Public Library of Science One. 2009. 4: e5683 1-12.

Citation

Wei Jiang, Michael M. Lederman, Peter W. Hunt, Scott F. Sieg, Kathryn Haley, Benigno Rodriguez, Alan Landay, Jeffrey N. Martin, Elizabeth Sinclair, John Spritzler, Ava I. Asher, Steven G. Deeks, Daniel C Douek, Jason M. Brenchley. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. Journal of Infectious Diseases. 2009. 199: 1177¿85.

Citation

Zhaohui Su, J. Reeves, Amy Krambrink, Eoin Coakley, Michael Hughes, Cong Han, Charles Flexner, Timothy J. Wilkin, Paul Skolnik, Wayne Greaves, Daniel R. Kuritzkes, Roy (Trip) Gulick. Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211. Journal of Infectious Diseases. 2009. 200: 1724-28.

Citation

Samir K. Gupta, Marlene Smurzynski, Nora Franceschini, Ronald J. Bosch, Lynda Anne Szczech, Robert C Kalayjian. The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.. Antiviral Therapy. 2009. 14: 543-9. PMID: 19578239

Citation

Rebecca J. Basham, D. Richardson, Cara Sutcliffe, David W. Haas. Effect of HIV-1 infection on human DNA yield from saliva.. HIV Clinical Trials. 2009. 10: 282-5. PMID: 19723616

Citation

Davey M. Smith, Selene Zarate, Hai Shao, Satish K. Pillai, Scott L. Letendre, Joseph K. Wong, Douglas D. Richman, Simon D. W. Frost, Ronald J. Ellis. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 2009. 385: 204-8.

Citation

Sara J. Conry, Kimberly A. Milkovich, Nicole L. Yonkers, Benigno Rodriguez, Helene B. Bernstein, Robert Asaad, Frederick P. Heinzel, Magdalena Tary-Lehmann, Michael M. Lederman, Donald D. Anthony. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. Journal of Virology. 2009. 83: 11175-87.

Citation

T. Chen, Grace M. Aldrovandi. Review of HIV Antiretroviral Drug Resistance.. Pediatric Infectious Disease Journal. 2009. 27: 749-52. PMID: 18664987